ArticleClinical and translational medicine2022

The brain-penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury.

Zubair Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.